Phlexglobal

Phlexglobal, a PharmaLex company, specialises in Trial Master File (TMF) management software and expert services for the pharmaceutical, biotech, and medical device industries. The company's core proposition centres on helping clinical trial sponsors and contract research organisations (CROs) achieve and maintain inspection-readiness through a combination of purpose-built eTMF technology, experienced TMF practitioners, and structured document management processes.

Phlexglobal frames its approach around what it calls the "TMF Health Zone" — a state of ongoing order, stability, and control over TMF quality, completeness, and timeliness. Achieving this requires the right people, processes, and technology working together, and the company positions itself as an authority across all three dimensions, having supported hundreds of regulatory inspections worldwide.

eTMF Technology Products

• A next-generation eTMF platform described as AI-ready from day one, designed to reduce TMF inspection risk and increase team productivity by minimising document misfiles through advanced AI capabilities.
• Purpose-built eTMF software constructed on TMF best practices, aimed at improving inspection-readiness for sponsor organisations.
• A viewable and inspectable eTMF archive solution for closed studies originating from CROs, addressing gaps in the Trial Master File lifecycle after study completion.
• A dedicated eTMF product designed specifically for CROs, intended to give their customers confidence in TMF health from study planning through to final archive.

TMF Expert Services

• TMF Quality Review: A thorough quality assessment of a client's TMF, providing insight into its overall quality and completeness.
• TMF Heatmaps: A service that helps organisations identify potential problem areas within their TMF and supports a risk-based approach to remediation.
• Migrations and Imports: Assistance with moving TMF content between systems while ensuring compliance with GCP standards and regulatory requirements for essential documents.
• Mergers and Acquisitions Support: Assessment of an acquired drug programme's TMF readiness for inspection or regulatory submission, including identification and remediation of issues.
• TMF Study Owners: Dedicated TMF practitioners who work alongside client teams to manage the day-to-day challenges of TMF oversight and maintenance.
• Additional scalable services aimed at helping organisations maintain ongoing TMF health, with resources described as globally available.

Core Capabilities and Approach

• Combines expert human resources with process guidance and technology to improve productivity and inspection-readiness.
• Provides fast and accurate document processing services to augment clients' internal TMF teams.
• Applies AI technologies within its eTMF platform to reduce document misfiles and provide management insight into TMF quality, completeness, and timeliness.
• Supports the full TMF lifecycle, from initial study planning through quality review, close-out, and final archive.
• Publishes educational content including blogs, webinars, and articles covering topics such as TMF audit trails, quality reviews, and study close-out procedures under ICH E6 (R2).

Industry Focus and Resources

• Serves pharmaceutical, biotech, and medical device companies, as well as CROs operating in clinical research.
• Offers global resources and has accumulated experience across a significant number of studies and documents processed.
• Provides inspection preparedness guidance, including published resources such as a TMF inspection guide intended for organisations that receive an inspection notice with limited preparation time.

Phlexglobal operates as part of the PharmaLex group and presents itself as a specialist authority in TMF management, combining proprietary software with a professional services capability intended to reduce inspection risk and support regulatory compliance throughout the clinical trial process.